Global health R&D at work in Illinois
Researchers at the University of Illinois College of Medicine at Rockford are conducting clinical trials of a vaccine candidate against lymphatic filariasis (LF), one of the world’s most profoundly disfiguring diseases. Commonly known as elephantiasis, LF is transmitted by mosquitos carrying parasitic worms. Currently, at least 36 million people worldwide are living with the severe pain, disability, and stigma of the disease; and 856 million people are at risk